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Aim: Extramammary Paget’s disease is an uncommon skin tumor occurring mostly in the 
genitoperineal region. Previous reports have shown that frequent expression of androgen 
receptor suggests tumor proliferative effects of androgens on Paget cells. 
Androgen-converting enzymes, such as 5α-reductase, which locally produces a bioactive 
androgen, have recently gained attention in studies of the intratumoral actions of androgens. 
We investigated correlations between the androgenic microenvironment and invasiveness in 
extramammary Paget’s disease, particularly in terms of sex differences. Methods and 
Results: We examined 58 cases of extramammary Paget’s disease (32 men, 26 women; 42 
non-invasive, 16 invasive) using immunohistochemistry for androgen receptor and 
5α-reductase. In all 58 cases, expression rates were 57% for androgen receptor and 55% for 
5α-reductase, with 38% double-positivity for androgen receptor and 5α-reductase. Only 
5α-reductase expression rate was significantly higher in invasive cases (81%) than in 
non-invasive cases (45%; p=0.042). For invasive cases, numbers of double-positive results 
for androgen receptor and 5α-reductase were significantly higher in men (90%) than in 
women (17%, p=0.039). Conclusion: Double-positivity for androgen receptor and 
5α-reductase in Paget cells suggests autocrine synthesis of androgen in extramammary 
Paget’s disease. The different hormonal microenvironments in male and female cases and 






 Extramammary Paget’s disease is a relatively rare cutaneous malignant neoplasm 
arising in apocrine gland-rich areas, such as the genitoperineal region and axilla1-3, and is 
principally classified as an apocrine gland tumor1. Normal apocrine glands of the skin 
consistently express androgen receptor (AR), but no detectable estrogen receptor and 
progesterone receptor4,5. Similarly, several previous reports have found that Paget cells 
frequently expresses only AR, but not estrogen receptor or progesterone receptor6-8. These 
findings have suggested the tumor proliferative effects of androgens on Paget cells 6-8. 
 In peripheral tissues, a large population of steroid hormones are locally synthesized 
by steroid-producing enzymes from circulating precursor steroids9. Bioactive sex-hormones 
are produced in the target cells themselves (autocrine) or neighbouring cells (paracrine)9. 
Additionally, the importance of the local synthesis of bioactive sex-hormones has recently 
been noticed in hormone receptor-positive cancers9,10. As for androgen synthesis, 
5α-reductase (5αR) mainly catalyzes the conversion of testosterone to a bioactive 
androgen10,11. Two isoforms of 5αR have been detected: 5αR type 1, expressed in the liver 
and skin; and 5αR type 2, localized in the liver, prostate, seminal vesicle, and 
epididymis10,12. Androgens are synthesized primarily by 5αR type1. Clarification of 5αR 
expression and relationships between AR and 5αR of Paget cells would thus reveal the 
androgenic microenvironment of extramammary Paget’s disease. 
 Paget cells are generally located in the epidermis (so-called carcinoma in situ) for a 
long period in the early stage. Then, with disease progression, Paget cells invade the dermis. 
Once invasive growth occurs, Paget cells often metastasize to lymph nodes and/or other 




invasion and metastasis of cancers often vary with the hormonal microenvironment. For 
example, in prostate carcinoma, 5αR type1 reportedly correlates with immunoreactivity for 
AR and tumor aggressiveness13. In extramammary Paget’s disease, the association between 
tumor proliferation and androgenic microenvironment has yet to be examined. Thus, 
differences between extramammary and mammary Paget’s disease have been discussed8. 
However, sex differences in extramammary Paget’s disease remain unclear, while this 
tumor often occurs in not only female but also male1,3. 
 The present study immunohistochemically investigated expressions of AR and 5αR, 
and estimated correlations between these expressions and clinicopathological factors 
including sex, invasiveness, and local recurrence and metastasis. 
 
Materials and methods 
 The surgical pathology files of Kanazawa University Hospital and Kanazawa 
Medical Center from 1990 to 2008 were reviewed for extramammary Paget’s disease, as 
determined by intraepidermal spread of large cells with pale to granular cytoplasm and 
occasional nuclear displacement by cytoplasmic vacuoles. Diagnosis of Paget cells was 
confirmed by positive staining for mucin1-3. We selected 58 patients (mean age, 71.5±9.4 
years; range, 48-91 years), including 32 men (mean age, 71.4 years; range, 48-90 years) and 
26 women (mean age, 72.1 years; range, 52-91 years). No significant difference in age was 
noted between sexes. Extramammary Paget’s disease cases were further divided into groups 
according to histological findings of invasion: non-invasive cases (i.e., usual intraepithelial 
extramammary Paget’s disease, n=42, 22 men, 20 women); and invasive cases (n=16, 10 




desmoplastic stromal reaction14. According to Goldblum et al., we determined minimal 
invasive cases as infiltration of Paget cells <1 mm in depth from the basement membrane of 
the epidermis, and massive invasive cases as infiltration of Paget cells >1 mm3. 
 Formalin-fixed, paraffin-embedded, serial 4-μm-thick sections mounted on 
precoated slides were immunohistochemically stained using the Avidin-Biotin Complex 
method. Primary antibodies were for AR (clone AR411, 1:100; DAKO, Glostrup, Denmark) 
and 5αR (5α-reductase type 1, rabbit polyclonal, 1:1000; provided by Dr. D. W. Russell; 
University of Texas Southwestern Medical Center, Dallas, TX). Antigen retrieval for AR 
was undertaken by pressure cooking in ethylenediaminetetraacetic acid buffer (pH 6.0) for 
5 min. Staining was performed using a Ventana standardized automated system (Ventana 
Medical Systems, Tucson, AZ) according to the manufacturer’s protocols. Immunopositive 
labeling of ≥10% among all cells was considered as a positive result, according to the 
standardized criteria for hormone receptors and hormone-producing enzymes11,15. The 
entire analysis of immunohistochemical findings was performed by two pathologists (S.K 
and Z.Y) who were blinded to the clinical features of the sample.  
 Statistical analyses were performed using Fisher’s test or the χ2 test, as appropriate, 
with the Yates correction and the Mann-Whitney rank-sum test for unpaired nonparametric 
data, to compare each group using the parameters of clinicopathological factors and 








(range, 2-22 cm), with no significant difference noted between non-invasive cases (mean, 
7.15±3.8 cm) and invasive cases (mean, 7.87±2.35 cm; p=0.4834). Tumor size was 
significantly larger in women (mean, 8.72±4.23 cm) than in men (mean, 6.17±2.01 cm; 
p=0.0049). Inguinal lymph node biopsy/dissection was performed in 18 cases (non-invasive 
cases, n=11; invasive cases, n=7). Lymph-node metastasis was observed in five cases (all 
male invasive cases) with significant correlations only seen for invasiveness of 
extramammary Paget’s disease (p=0.001), and not with tumor size, sex or age. Lymph-node 
metastasis was equally seen in minimal invasive cases (2/3, 66%) and massive invasive 
cases (3/6, 50%; p=0.235). Using follow up data on all cases with a mean interval of 55 
months. Local recurrence occurred in six cases (10%; non-invasive cases, n=4; invasive 
cases, n=2); no significant correlations were detected between local recurrence and other 
clinical parameters. No patient suffered distant metastasis or died of disease. 
 
Immunohistochemical findings for all cases of extramammary Paget’s disease
 Immunohistochemical findings of extramammary Paget’s disease are summarized in 
Table 1 and Figure 1. Among 58 cases, Paget cells were positive for AR in 33 cases (57%), 
5αR in 32 cases (55%), and double-positive for AR and 5αR in 22 cases (38%). AR and 
5αR were often detected in the same cells (Fig. 1), but the association between AR and 5αR 
in tumor cells was not significant (p=0.0739). Male cases showed relatively higher 
immunoreactivity for AR (men 66%, women 46%) and 5αR (men 63%, women 46%), but 
these differences did not reach the level of statistical significance (p=0.1346, p=0.1252, 
respectively). No association was observed between clinical factors such as tumor size, age, 





Differences between extramammary Paget’s disease with and without invasion 
 Compared with non-invasive cases, the expression rate of 5αR was significantly 
higher in invasive cases of extramammary Paget’s disease. Indeed, for 5αR expression, 
invasive cases was 81% (13/16) and non-invasive cases was 45% (19/42) (p=0.0423) (Table 
2, Fig. 2). In particular, in men, 5αR expression was more frequent in invasive cases (9/10, 
90%) than in non-invasive cases (11/22, 50%; p=0.0303). In comparison with 
intraepithelial Paget cells, relatively strong both AR and 5αR immunostaining was seen in 
peripheral nests of the invasion area (Fig.1c,d). In addition, in invasive cases, the number of 
double-positives for AR and 5αR was significantly higher in men (7/10, 70%) than in 
women (1/6, 17%; p=0.0389)(Fig.2). There were no differences in any parameters of 




 Frequent expression (approximately 60%) of 5αR was seen in Paget cells, and a 
new finding of about 40% double-positivity for AR and 5αR in Paget cells was identified. 
In addition, the close association between AR and 5αR in Paget cells suggests probable 
autocrine function of androgen. 
 Previous reports examining hormone receptors in extramammary Paget’s disease 
have mainly investigated women, with all women in the 23 cases described by Liegl et al.8, 
and 23 women and only 5 men examined by Diaz de Leon et al.7. Similar frequencies of AR 




Leon et al.7. Sex differences in extramammary Paget’s disease have not previously been 
noticed. However, in this report, examination of more male cases revealed that 
extramammary Paget’s disease in men shows higher positivity for AR and 5αR, along with 
higher double-positivity for AR and 5αR. Sex differences in the androgenic 
microenvironment would thus appear to be characteristic for extramammary Paget’s 
disease. 
 The invasiveness of extramammary Paget’s disease has been described in a few 
previous reports concerned with p53 overexpression14, high expression of MIB-1 and cyclin 
D116, and loss of MUC5AC17. For the first time, we have clarified androgenic differences 
correlated with the progression of extramammary Paget’s disease. Compared to non- 
invasive cases, invasive cases showed significantly higher expression of 5αR and 
double-positivity for both AR and 5αR. These findings indicate that local androgen 
production is associated with progressive proliferation of Paget cells, with a tendency 
toward stromal invasion. In addition, an androgenic role in the invasive growth of 
extramammary Paget’s disease was emphasized in male cases. Only male patients showed 
lymph-node metastasis, instead of smaller tumor size, in association with intratumoral 
androgenic action in male cases. In prostate carcinoma, biological aggressiveness and 
expression of AR and androgen-converting enzymes have been linked13. In contrast, some 
reports of breast carcinoma have shown that AR status relates to growth inhibition, 
particularly in cases positive for both AR and 5αR11. In brief, Paget cell proliferation was 
accelerated under an androgenic microenvironment, particularly in male cases, similar to 
prostate carcinoma, but not breast carcinoma. 




in hormone receptor-positive cancers. However, for the patients of extramammary Paget’s 
disease, surgical treatment remains the only treatment, whereas local recurrence occurred in 
about half of cases, due to the difficulty of determining adequate surgical margins in 
extramammary Paget’s disease and the resulting presence of residual tumor cells18. For 
such cases, topical chemotherapy with fluorouracil and radiotherapy has been used, but 
effective chemoradiation regimens for extramammary Paget’s disease have yet to be 
established2,18. Regarding high expression of AR in extramammary Paget’s disease, recently, 
androgen-deprivation therapy has been reported in the successful treatment of a patient of 
extramammary Paget’s disease with multiple metastases19. Due to local regulation of 
androgenic synthesis, 5αR inhibitors allowed decreased side-effects and longer period of 
hormonal response for prostate hormonal therapy20. Our findings indicate that regulation of 
5αR is one potential therapeutic tool for extramammary Paget’s disease, particularly for 
local recurrence and/or invasive state. 
 In conclusion, we have demonstrated the characteristic androgenic 
microenvironment of extramammary Paget’s disease. Higher expressions of 5αR and 
co-expressions 5αR and AR in invasive cases compared to non-invasive cases suggest that 
androgen might accelerate the invasive state of Paget cells. Interestingly, androgenic 
involvement in the invasiveness of Paget cells was emphasized in male. These novel 
findings of the androgenic microenvironment of extramammary Paget’s disease help to 
clarify the tumorigenesis, and seem likely to lead to the use of adjuvant endocrine therapy 





1. Watanabe S, Ohnishi T, Takahashi, Ishibashi Y. A comparative study of cytokeratin 
expression in Paget cells located at various sites. Cancer 1993; 72:3323-3330. 
2. Kodama S, Kaneko T, Saito M, Yoshiya N, Honma S, Tanaka K. A clinicopathologic 
study of 30 patients with Paget’s disease of the vulva. Gynecol Oncol 1995; 56:63-70. 
3. Goldblum JR. Hart WR. Vulvar Paget's Disease: A Clinicopathologic and 
immunohistochemical Study of 19 Cases. Am J Surg Pathol 1997;21:1178-1187.  
4. Shikata N, Kurokawa I, Adachi H, Tsubura A. Expression of androgen receptor in skin 
appendage tumors. An immunohistochemical study. J Cut Pathol.1995:22.149-153. 
5. Swanson PE, Mazoujian G, Mills SE, Campbell RJ, Wick MR. Immunoreactivity for 
estrogen receptor protein in sweat gland tumors. Am J Surg Pathol 1991, 15, 835-841. 
6. Lloveras B, Googe PB, Goldberg DE. Estrogen receptors in skin appendage tumors 
and Extrammary Paget’s disease. Mod Pathol 1991, 4, 487-490 
7. Diaz de Leon E, Carcangius ML, Prieto VG, Mc Ccue PA, Burchette JL, To G, Norris 
BA, Kovatich AJ, Sanchez RL, Kringmam HR, Gatalica Z. Extrammary Paget disease 
is characterized by the consistent lack of estrogen and progesterone receptors but 
frequently expresses androgen receptors. Am J Clin Pathol 2000;113:572-575. 
8. Liegl B, Horn L-C, Moinfer F. Androgen receptors are frequently expressed in 
mammary and extrammary Paget’s disease. Mod Pathol 2005;18:1283-1288. 
9. Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, Sasano H. Sex 
steroid-producing enzymes in human breast cancer. Endocrine-related cancer. 
2005;12:701-720. 




Biochem 1994 63:25-61. 
11. Suzuki T, Darnel AD, Akahira J, Ariga N, Ogawa S, Kaneko C, Takeyama J, Moriya T, 
Sasano H. 5α-reductase in human breast carcinoma: possible molecular of in situ 
androgenic actions. J Clin Endocrinol Metab 2001;86:2250-2257. 
12. Thigpen AE, Silver RI, Guileyardo JM, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, 
Hayashi S, Sasano H. Tissue distribution and ontogeny of steroid 5α-reducatse 
isozome expression. J Clin Invest1993.92;903-910. 
13. Wako K, Kawasaki T, Yamana K, et al. Expression of androgen receptor through 
androgen-converting enzyme is associated with biological aggressiveness in prostate 
cancer. J Clin Pathol 2008. 61(4):448-54.   
14. Zhang C, Zhang P, Sung CJ, Lawrence WD. Overexpression of p53 is correlated with 
stromal invasion in extrammary Paget’s disease of the vulva. Hum Pathol 
2003.880-885. 
15. Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, 
Tavassoli FA, Denk H. Androgen receptors frequently are expressed in breast 
carcinomas. Cancer 2003, 98:703-711. 
16. Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in 
invasive extramammary Paget’s disease. J Dermatol Sci 2008 50(3):117-84. 
17. Yoshi N, Kitajima S, Yonezawa S, Matsukita S, Setoyama M, Kanzaki T. Expression 
of mucin core protein in extramammary Paget’s disease. Pathol Int 2002:52;390-399. 
18. Kürzl RG. Paget’s disease. Semi Dermatol 1996;15 (1) 60-66. 
19. Yoneyama K, Kameda N, Kinoshita K, Kawashima T, Otani M, Endo H, Shinkai H, 




extramammary Paget’s disease. Br J Dermatol 2005;153(4):853-5. 
20. Flüchter SH, Weiser R, Gamper C. The role of hormonal treatment in prostate cancer. 




LEGENDS TO FIGURES 
Figure 1. Immunohistochemical findings for androgen receptor and androgen-synthesizing 
enzymes in extramammary Paget’s disease. Tumor cells are diffusely and strongly positive 
for androgen receptor in the nuclei of Paget cells (a,c) and 5α-reductase in the cytoplasm of 
Paget cells (b,d) Peripheral nests in the invasive area show stronger immunoreactivity for 
both AR (c) and 5α-reductase (d) than non-invasive area. 
 
Figure 2. Numbers of cells showing double-positive and double-negative results for 
androgen receptor and 5α-reductase in extramammary Paget’s disease. Male cases with 
invasion are characterized by co-existence of androgen receptor and 5α-reductase. AR, 







Table 1. Comparison of AR and 5αR expression between male and female, and invasive and non-invasive cases of extramammary Paget’s disease
  Total Male cases Female cases   Non-invasive cases Invasive cases   
  (n=58) (n=32) (n=26) p value (n=42) (n=16) p value 
AR 33 (56.8%) 21 (65.5%) 12 (46.2%) 0.134 24 (57.1%) 9 (56.3%) 0. 951 
5αR 32 (55.2%) 20 (62.5%) 12 (46.2%) 0.122 19 (45.2%) 13 (81.3%) 0.042 
AR and 5αR double-positive 22 (37.9%) 15 (46.9%) 7 (26.9%) 0.116 14 (33.3%) 8 (50%) 0.242 
AR and 5αR double-negative 15 (25.8%) 6 (18.8%) 10 (38.5%) 0.121 13 (30.9%) 2 (10.5%) 0.263 




Table 2. Comparison of AR and 5αR expression among subgroups of extramammary Paget’s disease. 
    
  
  Male  
non-invasive cases
Female  




Invasive cases P-value 1 P-value 2 
    (n=22) (n=20)  (n=10) (n=6)     
AR  14 (63.6%) 10 (50%)  7 (70%) 2 (33.3%) 0.725 0.152 
5αR  11 (50.0%) 8 (40%)  9 (90%) 4 (66.7%) 0.030 0.073 
AR and 5αR double positive 8 (36.4%) 6 (30%)  7 (70%) 1 (16.7%) 0.077 0.039 
AR and 5αR double negative 5 (22.7%) 8 (40%)  1 (10%) 1 (16.7%) 0.554 0.696 
AR, androgen receptor; 5αR, 5α-reductase 
p-value 1; Among male cases, compare with invasive and non-invasive cases of extramammary Paget’s disease 
p-value 2; Among invasive cases, compare with male and female cases of extramammary Paget’s disease
